NYSE:TMO

Thermo Fisher Scientific Q2 2026 Earnings Report

Thermo Fisher Scientific logo
$469.27 +5.26 (+1.13%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$470.84 +1.58 (+0.34%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific EPS Results

Actual EPS
N/A
Consensus EPS
$5.74
Beat/Miss
N/A
One Year Ago EPS
N/A

Thermo Fisher Scientific Revenue Results

Actual Revenue
N/A
Expected Revenue
$11.71 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Thermo Fisher Scientific Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Wednesday, July 22, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Thermo Fisher Scientific Earnings Headlines

Big Oil knew about this for 50 years
In the 1970s, Chevron, Unocal, and Texaco all drilled the same energy source - and walked away to protect oil profits. One company spent sixty years quietly proving them wrong. Now Google has signed a 15-year contract, Bill Gates has committed $100 million, and a July 4th government decision could hand this sector its biggest catalyst yet. The oil majors are scrambling back in, but one company already owns the entire chain.tc pixel
3 Reasons TMO is Risky and 1 Stock to Buy Instead
See More Thermo Fisher Scientific Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Thermo Fisher Scientific? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Thermo Fisher Scientific and other key companies, straight to your email.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE:TMO) (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies. Customers span academic and government research institutions, pharmaceutical and biotech firms, hospitals and clinical labs, and industrial and environmental testing organizations. The company’s product portfolio ranges from benchtop tools and reagents to high-end mass spectrometers, genomic sequencing platforms, and bioprocessing systems used in drug development and manufacturing.

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific was formed through the 2006 combination of Thermo Electron and Fisher Scientific and has since grown its global footprint through organic investment and strategic acquisitions, including notable transactions that expanded its molecular and bioproduction capabilities. The company maintains operations and sales across North America, Europe, Asia-Pacific and other international markets, supporting a global customer base.

Thermo Fisher is led by an executive team responsible for overseeing its diverse portfolio and global operations; the company emphasizes innovation, regulatory compliance and customer services as core components of its strategy to serve life science research, clinical diagnostics and industrial markets.

View Thermo Fisher Scientific Profile